Rezultati - Imogen Caird

Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway od Maria M. Rubinstein, David M. Hyman, Imogen Caird, Helen Won, Krysten Soldan, Kenneth Seier, Alexia Iasonos, William P. Tew, Roisin E. O’Cearbhaill, Rachel N. Grisham, Martee L. Hensley, Tiffany A. Troso-Sandoval, Paul Sabbatini, Joyce Guillen, S. Duygu Selçuklu, Catherine Zimel, Jean Torrisi, Carol Aghajanian, Vicky Makker

Polni tekst Polni tekst